25.10 (1.36%) Sun Pharmaceutical Industries has informed that it has enclosed press release relating to presentation of long-term follow-up data for ILUMYA at the 28th European Academy of Dermatology and Venereology Congress (EADV) in Madrid, Spain.
The above information is a part of company’s filings submitted to BSE.